American Strategic Investment (NYC) - 2024 Q4 - Earnings Call Presentation
2025-03-19 15:23
AMERICAN STRATEGIC INVESTMENT CO. Fourth Quarter Investor Presentation 0 196 Orchard Street Retail Condominium - New York, NY_ Fourth Quarter 2024 Highlights Manhattan focused real estate portfolio features an underlying tenant base in core commercial businesses, and an attractive top 10 tenant base that is 77% Investment Grade(1)(2) Highlights ✓ Portfolio Occupancy(1) of 80.8% with a weighted-average Remaining Lease Term(1) of 6.3 years ✓ Solid tenant base featuring government agencies and Investment Grade ...
HUTCHMED(HCM) - 2024 Q4 - Earnings Call Presentation
2025-03-19 12:31
GLOBAL COMMERCIAL PORTFOLIO NEXT-GENERATION INNOVATIVE PLATFORM 0000po HUTCHMED March 2025 Nasdaq/AIM:HCM | HKEX:13 Safe harbor statement & disclaimer The performance and results of operations of the HUTCHMED Group contained within this presentation are historical in nature, and past performance is no guarantee of future results. 2 Agenda Weiguo Su Opening 1 Chief Executive Officer & Chief Scientific Officer Financial review & outlook Johnny Cheng 2 Chief Financial Officer Commercial delivery George Yuan 3 ...
GDS(GDS) - 2024 Q4 - Earnings Call Presentation
2025-03-19 12:06
4Q24 & FY24 Earnings Call 19 March 2025 NASDAQ: GDS HKEX: 9698 © GDS 2016 0 GDS FY24 HIGHLIGHTS (1)(2) | Customer Commitments • | New customer commitments (net) of +11,055 sqm | | --- | --- | | • | Total area committed increased by 1.8% y/y to 629,997 sqm | | Customer Move-In | • Additional area utilized (net) of +47,792 sqm | | --- | --- | | | • Total area utilized of 453,094 sqm, +11.8% y/y, and utilization rate of 73.8% | This presentation contains forward-looking statements within the meaning of Section ...
Inovio Pharmaceuticals(INO) - 2024 Q4 - Earnings Call Presentation
2025-03-19 00:49
Fourth Quarter & Full Year 2024 Financial Results • March 2025 Agenda Introduction Jennie Willson, Director, Communications CEO Perspective & Corporate Progress Jacqueline Shea, PhD, President & Chief Executive Officer INO-3107 Update Michael Sumner, MBBS, MBA, Chief Medical Officer Steve Egge, Chief Commercial Officer Financial Results Peter Kies, Chief Financial Officer 2 Forward-Looking Statements This presentation includes statements that are, or may be deemed, "forward-looking statements," within the m ...
StoneCo(STNE) - 2024 Q4 - Earnings Call Presentation
2025-03-18 23:21
Earnings Presentation Risks that contribute to the uncertain nature of the forward-looking statements include, among others, risks associated with the Company's ability to anticipate market needs and develop and deliver new and enhanced products and services functionalities to address the rapidly evolving market for payments and point-of-sale, financial technology, and marketing services; the Company's ability to differentiate itself from its competition by delivering a superior customer experience and thro ...
OmniAb(OABI) - 2024 Q4 - Earnings Call Presentation
2025-03-18 21:59
Q4 and Full Year 2024 Financial Results & Business Update Nasdaq: OABI March 18, 2025 1 Disclaimer 2 We caution you that this presentation contains forward-looking statements. All statements other than statements of historical facts contained in this presentation, including statements regarding our future results of operations and financial position, including our financial guidance for 2025, business strategy, our expectations regarding the application of, and the rate and degree of market acceptance of, o ...
Sundial(SNDL) - 2024 Q4 - Earnings Call Presentation
2025-03-18 17:25
Forward-looking statements Certain statements contained in this presentation may constitute forward-looking information and statements. All statements in this presentation, other than statements of historical fact, that address events or developments concerning SNDL Inc. ("SNDL" or the "Company") that SNDL expects to occur are "forward-looking information and statements". Forward-looking information and statements are often, but not always, identified by the use of words such as "seek", "anticipate", "plan" ...
XIAOMI(XIACY) - 2024 Q4 - Earnings Call Presentation
2025-03-18 12:17
Financial Performance - Xiaomi's total revenue reached RMB 365.9 billion, a 35.0% year-over-year increase[10] - Adjusted net profit was RMB 27.2 billion, up 41.3% year-over-year[10] - The gross profit margin was 20.9%[10] - R&D expenses are expected to exceed RMB 100 billion from 2021 to 2025[18] Smartphone Business - Global smartphone shipments ranked No 3 with a 13.8% market share in 2024[13] - Mainland China smartphone market share increased by 1.7 percentage points year-over-year[13] - Premium smartphones accounted for 23.3% of total smartphone units sold in Mainland China, an increase of 3.0 percentage points[13] - Smartphone revenue reached RMB 191.8 billion, up 21.8% year-over-year[105] AIoT and Smart EV - IoT and lifestyle products revenue reached RMB 104.1 billion, up 30.0% year-over-year[108] - Smart EV and other new initiatives revenue reached RMB 32.8 billion[10, 112] - Delivered 136,854 vehicles in 2024 and targets 350,000 vehicle deliveries in 2025[13, 72]
Eastman Kodak(KODK) - 2024 Q4 - Earnings Call Presentation
2025-03-17 22:42
Fourth Quarter and Full Year 2024 Earnings Call March 17, 2025 Cautionary Statement Regarding Forward-looking Statements Pursuant to Safe Harbor Provisions of The Private Securities Litigation Reform Act of 1995 Cautionary Statement Regarding Forward-Looking Statements This presentation includes "forward-looking statements" as that term is defined under the Private Securities Litigation Reform Act of 1995. Forward–looking statements include statements concerning Kodak's plans, objectives, goals, strategies, ...
Quanterix(QTRX) - 2024 Q4 - Earnings Call Presentation
2025-03-17 21:47
March 17, 2025 Legal Information IMPORTANT ADDITIONAL INFORMATION " Fourth Quarter & Full Year 2024 Earnings In connection with the proposed acquisition of Akoya Biosciences, Inc. ("Akoya") by Quanterix (the "Merger"), Quanterix filed with the U.S. Securities and Exchange Commission (the "SEC") a registration statement on Form S-4, dated February 13, 2025 (the "Registration Statement"), which contains a preliminary joint proxy statement of Quanterix and Akoya and a preliminary prospectus of Quanterix (the " ...